Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Media processing method and device
TV wall mount
Soybean sequences associated with the FAP3 locus
Light-emitting device
Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
Optoelectronic component and method for producing an optoelectronic component
  Randomly Featured Patents
Gelled mineral oil skin protectant
8-stroke internal combustion engine
System and method for achieving local number portability
System and method for event driven virtual workspace
Test phone using SIP
Electron amplifier utilizing carbon nanotubes and method of manufacturing the same
Melamine resin, process for its manufacture and its use for the manufacture of coated wood-based materials and laminates
Timer device
Photochromic composition
Inferring informational goals and preferred level of detail of answers based at least on device used for searching